Aurobindo Pharma USA (APUSA) has successfully completed its acquisition of Lannett Company. APUSA is a major part of the larger drug company Aurobindo Pharma Limited. This big business move happened right after getting official permission from the United States government group known as the Federal Trade Commission on June 18, 2026.
The company shared this important news with the public and stock market experts through official letters and news releases later that same month. Starting on June 29, 2026, Lannett officially became a full part of the APUSA family. It will now do business under the new name Lannett Company LLC.
The leaders at APUSA said they will start integrating the two companies right away. Their main goal during this major change is to ensure that patients do not experience delays or problems obtaining the essential medicines they need every day. They also want to maintain strong relationships with all their business partners and provide ample support to their workers as everything settles down.
By combining their capabilities and resources, the combined company hopes to make essential medicines much easier for people to get. This teamwork will help create great long-term value for patients, customers, and everyone involved in the business.
You Might Also Like- BAAS Technologies Concludes Pre-Seed Round with ₹5 Crore Funding
As part of the acquisition, APUSA welcomed more than 400 Lannett employees into its team. This adds a lot of great talent, extra strength, and skill to their daily operations. The bosses at APUSA also thanked the leaders at Lannett for doing a wonderful job guiding everyone through a smooth, friendly transition.
